DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Popat SC-F A, Polydoropoulou V, Shah R. et al.
Multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): results from the European Thoracic Oncology Platform (ETOP 9–15) PROMISE-meso trial.
Ann Oncol 2019;
30: v931
DOI: 10.1093/annonc/mdz394.091.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.